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Correlation Between Indices of Kidney Function (Estimated Glomerular Filtration Rate
and Proteinuria) and Syntax Score in Non- Diabetic Chronic Kidney Disease Patients
Mohamed Abdel Ghany, Mena Wageeh, Salwa Roshdy
Assuit University, Asyut, Egypt
Background: Chronic kidney disease (CKD) is highly prevalent with signiﬁcant
morbidity and mortality rates among patients with coronary artery disease (CAD). The
SYNTAX Score (Synergy Between Percutaneous Coronary Intervention With
TAXUS and Cardiac Surgery) predicts the outcomes of patients undergoing percu-
taneous coronary intervention. Our aim was to evaluate the correlation between CKD
and severity of coronary artery stenosis by calculating SYNTAX Score in non diabetic
CKD patients.
Methods: SYNTAX Score was calculated for 180 non diabetic patients with CKD
scheduled for coronary angiography. Serum creatinine and 24 hour proteinuria prior to
invasive coronary angiography (ICA) were assessed in all patients. Patients were
divided into 2 groups according to their estimated glomelular ﬁltration rate, (group 1
with eGFR 15 to < 30 ml/min per 1.73 m2) and (group 2 with eGFR  30 ml/min
per 1.73 m2).
Results: coronary arteries lesions complexity increased progressively with decreasing
kidney function as there were signiﬁcant negative correlation between e-GFR and
SYNTAX Score (r ¼ -0.5, P ¼ 0.0004) and signiﬁcant positive correlation between 24
hr proteinuria and SYNTAX Score (r ¼ 0.6, p ¼ 0.0001). A multivariate regression
analysis was performed for the predictors of the SYNTAX Score, including age and
e-GFR. In this analysis, e-GFR (ß ¼-0.098, p ¼ 0.01) and age (ß ¼ 0.35, p ¼ 0.001)
were both independent predictors of higher Syntax Score
Conclusion: Serum creatinine, estimated glomerular ﬁltration rate and 24 hours
proteinuria were predictors of higher SYNTAX Score.CRT-143
The Two Current Approaches to Thread Stent for Performing the Szabo Technique:
Problems Related with Each Approach, and a Proposal of Stent Designed to Decrease
Complications
Raúl Valdesuso, II,1 Juan Ramon Gimeno,2 Francisco Javier Lacunza,2
Julio Antonio Rodriguez,3 Raul Cecilio Rodriguez,4 Hector Alberto Fleites,5
Albert Toruncha6
1IDC Salud Albacete, Albacete, Spain; 2Hospital Virgen de la Arrixaca, Murcia, Spain;
3Hospital Comarcal de Hellin, Albacete, Spain; 4Hospital Virgen de la Montaña, Caceres,
Spain; 5Clínica La Milagrosa, Madrid, Spain; 6Assuta Medical Center, Tel Aviv, Israel
Background: Stenting ostial and/or bifurcated lesions (L) constitute always a chal-
lenge. Szabo Technique (SzT) is a simple way to deal with these problems, but Stent
can be damaged during the process increasing nonfatal complication (NFC).
Methods: From Jan’08 to May’13. SzT was attempted in 266 patients (pts) (65  5
years; 68% male). Different brand of stents were used. Before pre-dilating the target L,
an “Anchor Guide Wire” (AGW) is placed into “non-stenotic” side branch, and Its
proximal stiff tip is attempted crossing through the proximal Stent’s cell, by 2 Types of
approaches (Tyapps): (Type I) inﬂating Stent’s balloon to lifting up its proximal crown
(rest of stent is keeping inside its protective sheath); (Type II) by bending the Stent
(looking for “ﬁsh ﬂake effect”) attempting to separate its proximal cell from balloon.
Results: A total of 283 L (82% by transradial approach) were attempt with SzT.
Guide Catheter (GC) Fr used (%) were: 6F: 17; Sheathless GC, 6.5 Fr: 26; 7Fr GC:
28 and Sheathless 7.5 GC: 29. Total Stent used 291. Total Stent Implanted by SzTc:
268 (92%) Mean stent length and diameter was 13.47 5.2 mm and 2.77  1.14 mm.
Tyapps used were (%): 43 Type I and 57 Type II. Failure of Stent delivery was due to:
puncture of Stent’s balloon: 3 (13%) (all in Tyapps II), stent dislodgment 7 (30%) (6 in
Tyapps I); Stent non eligible due to deformation by any Tyapps: 5 (22%); others causes
(guide wire twisting, failure of reaching the L, etc: 8 (33%). In all SzT failure, pro-
cedure was successfully ended with any other stenting technique without NFC.
Conclusions: SzT is highly successful technique, but both Tyapps for Stent threading
involves risk of Stent damage (5% in our series), that cause decreasing its rate of success
delivery and increasing NFC.
SzT is highly successful technique, but both Tyapps for Stent threading involves risk
of Stent damage (5% in our series), that cause decreasing of its delivery success rate and
increasing of NFC. Due to these results, we designed with Hexacath (Paris France)
one Stent with a dedicated cell (coming from factory), to simplify the threading of
AGW, avoiding balloon puncture or Stent deformation. Our Stent called Titan V, has
been successfully implanted in test benches and animal models and currently is under
evaluation for CE mark.
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Comparison of Rotational Atherectomy Versus Cutting Balloon Angioplasty Followed by
Stent Implantation for the Treatment of Native De Novo Lesions
Wenjie Tian, Rebecca Torguson, Alfazir Omar, Hideaki Ota, Fang Cheng, Joshua Loh,
Lakshmana Pendyala, Marco De Magalhaes Pereira, Nevin Baker,
Ricardo Escarcega Alarcon, Saar Minha, Lowell Satler, Augusto Pichard, Ron Waksman
MedStar Heart Institute, Washington, DC
Background: Limited information is available on the clinical outcome differences
between rotational atherectomy (ROTA) and cutting balloon angioplasty (CA) fol-
lowed by stents implantation.
Methods: Clinical data of 986 patients with native de novo coronary lesions who
underwent ROTA (n¼413) or CA (573) followed by stent implantation from 2003-
2013 were retrospectively analyzed. The occurrence of major adverse cardiac events
(MACE), deﬁned as all-cause death, myocardial infarction (MI) or target lesion
revascularization (TLR) were compared between the two groups at 6 months, 1 and 2
years.
Results: Baseline clinical and procedural characteristics were similar between the two
groups, except for greater age (71.710.6 vs. 67.611.2 years, p<0.01), higher
prevalence of type C lesion (54.6% vs. 37.8%, p<0.01), greater length (20.86.5 vs.
18.9 6.6mm, p<0.01) and number of stents (1.71.0 vs. 1.40.9, p<0.01) in the
ROTA group. The rate of procedure success (98.0% vs. 98.6%, p¼0.516) and DES
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no difference in MACE rate and occurrence of stent thrombus between the two
groups (p¼NS), however, higher all-cause death rate in the ROTA group at 6 months,
1 and 2 years (p<0.05).
Conclusions: ROTA was used in patients with more lesion complexity. However, the
MACE rate was comparable between ROTA and CA at 6 months, 1 and 2 years.Clinical events
Cutting balloon
(n¼573)
Rotational atherectomy
(n¼413) p value
In-hospital Death/
QWMI/CABG
1.4% 2.0% 0.5166 monthAll-cause death (%) 2.7 7.1 0.007MI (%) 1.8 1.1 0.747TLR (%) 4.0 2.6 0.307Deﬁnite ST (%) 0.5 1.1 0.654Composite MACE 6.5 9.2 0.1841 yearAll-cause death (%) 4.7 10.3 0.007MI (%) 2.6 2.0 0.665TLR (%) 6.3 4.9 0.454Deﬁnite ST (%) 0.6 1.0 0.655Composite MACE (%) 10.6 14.5 0.1452 yearAll-cause death (%) 9.1 15.7 0.025MI (%) 4.5 3.2 0.499TLR (%) 10.3 8.4 0.496Deﬁnite ST (%) 0.7 1.4 0.655Composite MACE (%) 18.2 22.8 0.205MI: Myocardial infarction; QWMI: Q-wave myocardial infarction; CABG: Coronary artery bypass
grafting; TLR: Target lesion revascularization; ST: Stent thrombus; MACE: Major adverse cardiac
events.
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Clinical Impact of Diabetes Mellitus on Long-term Clinical Outcomes in Patients
Treated with Everolimus-Eluting Stent for Multivessel Percutaneous Coronary
Intervention
Lakshmana Pendyala, Joshua Loh, Al F. Omar, Sa’ar Minha, Marco DeMagalhaesPereira,
Hideaki Ota, Nevin Baker, Ricardo EscarcegaAlarcon, Radhika Gadesam,
Rebecca Torguson, Lowell Satler, Augusto Pichard, Ron Waksman
MedStar Heart Institute, Washington, DC
Background: Newer generation stents by means of more biocompatible components
limiting inﬂammatory response have led to signiﬁcant improvement in the cardio-
vascular outcomes.
Objective: The purpose of the present study is to evaluate the long term outcomes of
diabetic patients undergoing multivessel PCI with the use of everolimus-eluting stent
(EES).
Methods: 350 consecutive diabetic patients that underwent multivessel PCI deﬁned
as 2 vessel with EES during the same index procedure were analyzed. Patients were
further stratiﬁed by the need for insulin (n¼55) or oral medications only (n¼82) for
control of blood glucose in comparison once that were non-diabetic (n¼214). Primary
end point (MACE) was the combined incidence of death, and non-fatal Q-wave
myocardial and target vessel revascularization (TVR) at one year.
Results:Diabetic group had more African-Americans, and higher hypertension, renal
failure and higher body mass index compared to non-diabetics. At 1 year there was no
difference in rates of MACE, between the non-diabetics and oral diabetics (7% vs.
12%, p¼0.15) but the MACE rates were higher in insulin treated diabetics compared
to non-diabetics (24% vs. 7%, p<0.001). Similar trends were noted with TVR, with
no difference between non-diabetics and oral diabetics (4.3% vs. 10%, p¼0.09) but
signiﬁcantly higher TVR rate in the insulin group compared to non-diabetics (20% vs.4.3%, p<0.001). There were no differences in the over-all mortality and no cases of
deﬁnitive stent thrombosis were noted in the entire cohort at 1 year.
Conclusions: Despite the higher risk nature of multivessel intervention in diabetic
patients, with the use of newer generation EES stents, the event rates at one year in
oral-diabetics were similar to the non-diabetic population. But patients with insulin
treated diabetes continue to be a challenging population.Coronary
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Coronary Heart Disease and Genetic Polymorphisms; Clinical, Angiographic, Procedure
Technique and Long-Term Follow-Up Evaluation Post Percutaneous Coronary
Intervention; Major Events and Restenosis
Ivana Borges,1 Rosemaria Andrade,1 Edison Peixoto,2 Rodrigo Peixoto,3 Ricardo Peixoto4
1Polícia Militar do Estado do Rio de Janeiro - Governo do Estado, Rio de Janeiro, Brazil;
2Universidade Federal Fluminense, Rio de Janeiro, Brazil; 3National Institute of
Cardiology, Rio de Janeiro, Brazil; 4Aloysio de Castro State Institute of Cardiology, Rio de
Janeiro, Brazil
Background: There are clinic and genetic polymorphism differences in coronary ar-
tery disease (CHD). Percutaneous coronary intervention (PCI), clinic, angiographic,
procedure technique may inﬂuence the evolution, major events (death, AMI, revas-
cularization) and clinical restenosis. This study aims to evaluate if there are genetic
polymorphism differences between patients with and without CHD and if it would
inﬂuence in long-term follow-up after PCI.
Method and Results: It was studied two groups: the coronary disease group (CDG)
with 182 patients of a closed health system with CHD that were submitted to PCI
from 2001 and 2007 and to genetic follow-up evaluation until 12/31/2008; the control
group (CG) with 36 patients, were angiographically normal and were also submitted to
genetic evaluation. The polymorphisms evaluated were the ACE I/D and A166C
(AT1R). In this period 221 procedures were performed in 182 patients of CDG. Qui
square, Fisher exact and Student t test were used. Cox multivariate regression analysis
were not performed because only three clinical characteristics and A166C had p<0.10
in univariable analysis.
The CG and CDG patients were: female 20 (55.6%) and 49 (26.9%), (P¼0.0007);
age 55.911.1 and 60.810.5 (P¼0.0100); tobacco smokers 5 (13.9%) and 67
(36.8%), (P¼0.0132); diabetes 4 (11.1%) and 48 (26.4%), (P¼0.0802); hypertension
29 (80.6%) and 146 (80.2%), (P¼0.9631); dyslipidemia 14 (38.9%) and 112 (61.5%),
(P¼0.0119); family history 12 (33.3%) and 60 (33.0%), (P¼0.9659); obesity 9 (25.0%)
and 60 (33.0%), (P¼0.3476); ACE polymorphism DD 16 (44.5%), DI 17 (47.2%), II
3 (8.3%) and DD 81 (44.5%), DI 70 (38.5%), II 31 (17.0%), (P¼0.3612); A166C
